Drug Trial Radar · NCT06890533
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery
Last checked: Nov 19, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
560
Planned (sponsor's estimate)
Start
May 14, 2025
Primary completion
Apr 17, 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Conditions
- Pain
Interventions
Experimental: YZJ-4729Drug
Loading dose + demand dose
Placebo Comparator: SalineDrug
Loading dose + demand dose
Active Comparator: MorphineDrug
Loading dose + demand dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- the Sum of Pain Intensity Differences Over 24 Hours at restTime frame: 24 hours
Locations
49 sites in 1 country. Site status is shown where the registry gives one.
Cangzhou Central Hospital
Cangzhou, China
Cangzhou People's Hospital
Cangzhou, China
The First Hospital of Jilin University
Ch’ang-ch’un, China
Changde First People's Hospital
Changde, China
Changsha Hospital Affiliated to Hunan University
Changsha, China
The Fourth Hospital OF Changsha
Changsha, China
The Third Xiangya Hospital of Central South University
Changsha, China
Sichuan Provincial People's Hospital
Chengdu, China
The Second People's Hospital of Chengdu
Chengdu, China
The Third People's Hospital of Chengdu
Chengdu, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
Affiliated Zhongshan Hospital of Dalian University
Dalian, China
Deyang People's Hospital
Deyang, China
Dongguan People's Hospital
Dongguan, China
Ganzhou People's Hospital
Ganzhou, China
The First People's Hospital of Guangyuan
Guangyuan, China
Guangdong Province Traditional Chinese Medical Hospital
Guangzhou, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
The First Affiliated Hospital of Jinan University
Guangzhou, China
The Fourth Affiliated Hospital of Harbin Medical University
Ha’erbin, China
Haikou People's Hospital
Haikou, China
The Second People's Hospital of Hefei
Hefei, China
The First Affiliated Hospital of University of South China
Hengyang, China
Huzhou Central Hospital
Huzhou, China
The First Hospital of Jiaxing
Jiaxing, China
Liuzhou People's Hospital
Liuzhou, China
Liuzhou Workers' Hospital
Liuzhou, China
Luoyang Central Hospital
Luoyang, China
Ma'anshan People's Hospital
Ma’anshan, China
Mianyang Central Hospital
Mianyang, China
JiangXi Provincial People's Hospital
Nanchang, China
The Second Nanning People's Hospital
Nanning, China
The Second People's Hospital of Neijiang
Neijiang, China
Ningbo Medical Center Lihuili Hospital
Ningbo, China
Qingdao Central Hospital of Rehabilitation University
Qingdao, China
Shanghai First Maternity and Infant Hospital
Shanghai, China
Shanghai Fourth People's Hospital
Shanghai, China
Taizhou People's Hospital
Taizhou, China
The Second Hospital of Tianjin Medical University
Tianjin, China
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.